ESC Professional Premium Access

Predictors of successful cardioversion of recent-onset atrial fibrillation to sinus rhythm with orally inhaled flecainide

Congress Presentation

About the speaker

Professor Harry Crijns

Maastricht University Medical Centre (MUMC), Maastricht (Netherlands (The))
18 presentations
0 follower

5 more presentations in this session

Dronedarone as early rhythm control: post-hoc analysis of the ATHENA trial using EAST-AFNET4 criteria

Speaker: Professor J. Piccini (Durham, US)

Thumbnail

Amiodarone and Lung Toxicity in a real-life contemporary population

Speaker: Doctor G. Tsaban (Beer Sheva, IL)

Thumbnail

Chronic amiodarone therapy and mortality among atrial fibrillation patients; insights from a real-life contemporary population

Speaker: Doctor G. Tsaban (Beer Sheva, IL)

Thumbnail

Alleviation of AF related symptoms following acute conversion of recent-onset, symptomatic atrial fibrillation to sinus rhythm with flecainide acetate oral inhalation solution

Speaker: Professor J. Camm (London, GB)

Thumbnail

Amiodarone therapy and risk of primary lung cancer; insights from a real-life contemporary population study

Speaker: Doctor G. Tsaban (Beer Sheva, IL)

Thumbnail

Access the full session

Novel medication strategies in atrial fibrillation

Speakers: Professor H. Crijns, Professor J. Piccini, Doctor G. Tsaban, Doctor G. Tsaban, Professor J. Camm...
Thumbnail

About the event

Image

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk